Issue 3/2020
Content (20 Articles)
Unusual megakaryocyte aggregation mimicking bone marrow carcinomatosis
Tatsuya Konishi, Toru Motoi, Kazuhiko Kakihana
Who seeks finds. Gaucher’s disease: a rare case of thrombocytopenia
Nicola Sgherza, Antonella Quarta, Erminia Rinaldi, Annamaria Pasanisi, Maurizio Brocca, Domenico Pastore
Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision
Hirokazu Kashiwagi, Masataka Kuwana, Takaaki Hato, Toshiro Takafuta, Kingo Fujimura, Yoshiyuki Kurata, Mitsuru Murata, Yoshiaki Tomiyama
Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in β-thalassemia
Nur Suraya Che Yaacob, Md Asiful Islam, Heba Alsaleh, Ibrahim Khidir Ibrahim, Rosline Hassan
Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia
Jieling Jiang, Yu Cai, Liping Wan, Jun Yang, Chun Wang
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system
Yuto Nakajima, Keiji Nogami, Koji Yada, Takeshi Kawamura, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Masahiro Takeyama, Midori Shima
Circulating intranuclear proteins may play a role in development of disseminated intravascular coagulation in individuals with acute leukemia
Kayo Harada-Shirado, Xintao Wang, Hirotaka Mori, Masahiko Fukatsu, Hiroshi Takahashi, Akiko Shichishima-Nakamura, Satoshi Kimura, Hiroshi Ohkawara, Shingo Yamada, Takashi Ito, Takayuki Ikezoe
High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura
Ken Takase, Hirokazu Nagai, Moe Kadono, Takanori Yoshioka, Nobuyuki Yoshio, Yukio Hirabayashi, Takuo Ito, Morio Sawamura, Akihiro Yokoyama, Shinichiro Yoshida, Ikuyo Tsutsumi, Maki Otsuka, Youko Suehiro, Michihiro Hidaka, Isao Yoshida, Hisayuki Yokoyama, Hitoshi Inoue, Hiroatsu Iida, Maki Nakayama, Terutoshi Hishita, Hiromi Iwasaki, Akiko Kada, Akiko M. Saito, Yoshiaki Kuroda
The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin
Kento Umino, Kaoru Hatano, Shin-ichi Ochi, Harunobu Genda, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group
Hiroki Yamaguchi, Naoki Takezako, Kazuteru Ohashi, Koji Oba, Takashi Kumagai, Yasuji Kozai, Hisashi Wakita, Koh Yamamoto, Akira Fujita, Tadahiko Igarashi, Chikashi Yoshida, Kazuma Ohyashiki, Shinichiro Okamoto, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi
Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma
Koji Izutsu, Yosuke Minami, Noriko Fukuhara, Yasuhito Terui, Tatsuro Jo, Go Yamamoto, Takayuki Ishikawa, Tsutomu Kobayashi, Toru Kiguchi, Hirokazu Nagai, Tomoko Ohtsu, Stacey Kalambakas, Pierre Fustier, Shuichi Midorikawa, Kensei Tobinai
Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia
Hyejin Shin, Soo Young Choi, Kyung-Mi Kee, Soo-Hyun Kim, Seon-Young Yang, Su Young Jung, Hayeon Noh, Dae Young Zang, Dong-Wook Kim, Jangik I. Lee
A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma
Shigeo Fuji, Saiko Kurosawa, Yoshihiro Inamoto, Tatsunori Murata, Atae Utsunomiya, Kaoru Uchimaru, Satoshi Yamasaki, Yoshitaka Inoue, Yukiyoshi Moriuchi, Ilseung Choi, Masao Ogata, Michihiro Hidaka, Takuhiro Yamaguchi, Takahiro Fukuda
Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study
Shotaro Hagiwara, Hirokazu Nagai, Tomoko Uehira, Akiko M. Saito, Seiji Okada
Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity
Laura Viñas-Giménez, Laura Donadeu, Laia Alsina, Rafael Rincón, Elena Álvarez de la Campa, Ana Esteve-Sole, Albert Català, Roger Colobran, Xavier de la Cruz, Joan Sayós, Mónica Martínez-Gallo
PCDH17 functions as a common tumor suppressor gene in acute leukemia and its transcriptional downregulation is mediated primarily by aberrant histone acetylation, not DNA methylation
Le Thanh Nha Uyen, Yuji Amano, Lika’a Fasih Y. Al-Kzayer, Noriko Kubota, Jun Kobayashi, Yozo Nakazawa, Kenichi Koike, Kazuo Sakashita
Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation
Shin-ichi Tsujimoto, Ryota Shirai, Tomoyuki Utano, Tomoo Osumi, Kana Matsumoto, Yoko Shioda, Chikako Kiyotani, Toru Uchiyama, Takao Deguchi, Keita Terashima, Daisuke Tomizawa, Kimikazu Matsumoto, Motohiro Kato
Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand disease
Toshio Shigekiyo, Hikaru Yagi, Etsuko Sekimoto, Hironobu Shibata, Shuji Ozaki, Masanori Matsumoto
Muscle aches and pains: do I have leukemia?
Max Deschner, Chai Phua, Lalit Saini, Anargyros Xenocostas, Uday Deotare
Loss of nivolumab binding to T cell PD-1 predicts relapse of Hodgkin lymphoma
Reiki Ogasawara, Daigo Hashimoto, Junichi Sugita, Fumihiko Yamawaki, Tomoaki Naka, Tomoko Mitsuhashi, Shuichiro Takahashi, Naohiro Miyashita, Kohei Okada, Masahiro Onozawa, Yoshihiro Matsuno, Takanori Teshima